Celiberto, 2018 - Google Patents
Intestinal homeostasis and host defense as promoted by commensal bacteria and the colonic mucus layerCeliberto, 2018
View PDF- Document ID
- 6004402419684910212
- Author
- Celiberto L
- Publication year
External Links
Snippet
O trato gastrointestinal abriga a maior população de microrganismos no corpo humano, onde eles desempenham um papel importante na promoção da saúde do hospedeiro. A alteração na composição da microbiota pode levar à disbiose intestinal, que …
- 241000894006 Bacteria 0 title abstract description 91
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lazar et al. | Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer | |
| Sorbara et al. | Microbiome-based therapeutics | |
| US10898527B2 (en) | Therapeutic microbiota for the treatment and/or prevention of food allergy | |
| Adak et al. | An insight into gut microbiota and its functionalities | |
| Ranjha et al. | Nutritional and health potential of probiotics: a review | |
| Li et al. | The gut microbiota: A treasure for human health | |
| Papadimitriou et al. | Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches | |
| Sonnenborn et al. | The non-pathogenic Escherichia coli strain Nissle 1917–features of a versatile probiotic | |
| Glendinning et al. | The microbiota and helminths: sharing the same niche in the human host | |
| Rupa et al. | Recent advances in the role of probiotics in human inflammation and gut health | |
| Hemarajata et al. | Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation | |
| Zhu et al. | Bifidobacteria attenuate the development of metabolic disorders, with inter-and intra-species differences | |
| Idrees et al. | Probiotics, their action modality and the use of multi-omics in metamorphosis of commensal microbiota into target-based probiotics | |
| Shen et al. | Engineering the microbiome: a novel approach to immunotherapy for allergic and immune diseases | |
| Chen et al. | 2′-Fucosyllactose Promotes the Production of Short-Chain Fatty Acids and Improves Immune Function in Human-Microbiota-Associated Mice by Regulating Gut Microbiota | |
| Grady et al. | Microbial therapeutic interventions | |
| JP2022506726A (en) | Therapeutic microflora for the treatment and / or prevention of disbiosis | |
| Kumar et al. | Is regular probiotic practice safe for management of sepsis? | |
| Calo-Mata et al. | Intestinal microbiota: first barrier against gut-affecting pathogens | |
| Celiberto | Intestinal homeostasis and host defense as promoted by commensal bacteria and the colonic mucus layer | |
| Ostrowski et al. | Breastfeeding as a regulating factor of the development of the intestinal microbiome in the early stages of life | |
| Zhang et al. | Human Breast Milk: The Role of Its Microbiota and Metabolites in Infant Health | |
| Magrone et al. | Prebiotics and probiotics in aging population: effects on the immune-gut microbiota axis | |
| Devi et al. | Mechanistic Insights into Immune-Microbiota Interactions and Preventive Role of Probiotics Against Autoimmune Diabetes Mellitus | |
| Collado et al. | Human microbiome and diseases: a metagenomic approach |